Tarsus Pharmaceuticals, Inc. Common Stock (TARS) Stock Price, Quote & AI Analysis

Live TARS stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Tarsus Pharmaceuticals, Inc. Common Stock.

TradeVae provides AI-driven analysis and real-time market intelligence for Tarsus Pharmaceuticals, Inc. Common Stock (TARS), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

TARS
Tarsus Pharmaceuticals, Inc. Common Stock
real-time
$0.00 +0.00 (+0.00%)
Open
64.590000
High
66.880000
Low
64.320000
Volume
252,679
VWAP
-
Market Cap
$2,739,665,236.70
52W Range
$38.51 - $85.25
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Feb 23, 2026 Q4
After Hours
EPS Estimate: $-0.0938
Revenue Estimate: $147,531,780.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Tarsus Pharmaceuticals, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Tarsus Pharmaceuticals, Inc. Common Stock Overview

Company information

Company Overview

Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of therapeutic candidates. Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis. It is also developing TP-04 for the potential treatment of Ocular Rosacea and TP-05 as an oral tablet for the potential prevention of Lyme disease. The company was founded by Bobak Azamian and D. Michael Ackermann in 2017 and is headquartered in Irvine, CA.

Company Details
Market Cap
$2.83B
Shares Outstanding
42,449,105
Weighted Shares Outstanding
42,449,105
CEO
Bobak Azamian
Address
15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
Employees
323
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Tarsus Pharmaceuticals, Inc. Common Stock Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...